PortfoliosLab logoPortfoliosLab logo
ISIN
US98401F1057
CUSIP
98401F105
IPO Date
Dec 3, 2013

Highlights

Market Cap
$1.05B
Enterprise Value
$1.11B
EPS (TTM)
-$2.31
Total Revenue (TTM)
$92.84M
Gross Profit (TTM)
$87.61M
EBITDA (TTM)
-$10.29M
Year Range
$6.92 - $18.69
Target Price
$27.50
ROA (TTM)
-23.40%
ROE (TTM)
-33.44%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Xencor, Inc.

Often compared with XNCR:
XNCR vs. QQQM

Performance

XNCR Performance Chart

Xencor, Inc. (XNCR) is down 8.5% since the beginning of the year. At $14 per share, XNCR is trading 25.0% below its 52-week high of $19. Investors who bought $1,000 worth of XNCR shares 5 years ago would now be looking at an investment worth $383.


Loading charts...

S&P 500 Index

Returns By Period

Xencor, Inc. (XNCR) has returned -8.49% so far this year and 64.05% over the past 12 months. Over the last ten years, XNCR has returned 0.45% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.


Xencor, Inc.

1D
10.84%
1M
23.87%
YTD
-8.49%
6M
-12.27%
1Y
64.05%
3Y*
-18.15%
5Y*
-17.47%
10Y*
0.45%

Benchmark (S&P 500 Index)

1D
-0.37%
1M
-0.01%
YTD
9.16%
6M
8.64%
1Y
25.22%
3Y*
19.78%
5Y*
11.99%
10Y*
13.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

XNCR Monthly Returns History

Based on dividend-adjusted daily data since Dec 3, 2013, XNCR's average daily return is +0.09%, while the average monthly return is +1.73%. At this rate, an investment would double in approximately 3.4 years.

Historically, 48% of months were positive and 52% were negative. The best month was Dec 2013 with a return of +53.6%, while the worst month was Mar 2025 at -30.7%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 5 months.

On a daily basis, XNCR closed higher 49% of trading days. The best single day was Dec 3, 2013 with a return of +40.2%, while the worst single day was Mar 16, 2020 at -21.8%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-21.03%5.62%-5.56%-1.08%-0.42%17.93%-8.49%
2025-20.45%-15.97%-30.73%3.57%-27.40%-1.75%5.85%-2.28%44.28%25.40%17.74%-11.61%-33.38%
2024-11.92%22.73%-3.57%-5.38%13.47%-20.33%7.87%-14.35%14.98%4.48%21.85%-10.23%8.24%
202326.42%-2.40%-13.20%-5.20%2.50%-7.86%-2.72%-9.51%-8.33%-13.90%5.71%15.76%-18.47%
2022-14.33%-8.90%-14.79%-6.37%-10.61%22.57%4.82%-8.02%-1.55%7.78%6.14%-12.38%-35.09%
20214.86%7.69%-12.60%-1.16%-9.63%-10.32%-10.76%10.04%-3.57%21.13%-8.44%10.77%-8.04%

Benchmark Metrics

Xencor, Inc. has an annualized alpha of 6.14%, beta of 1.27, and R2 of 0.15 versus S&P 500 Index. Calculated based on daily prices since December 03, 2013.

  • This stock participated in 124.87% of S&P 500 Index downside but only 101.63% of its upside - more exposed to losses than it benefited from rallies.
  • R2 of 0.15 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
6.14%
Beta
1.27
0.15
Upside Capture
101.63%
Downside Capture
124.87%

Return for Risk

Risk / Return Rank

XNCR ranks 70 for risk / return — better than 70% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


XNCR Risk / Return Rank: 7070
Overall Rank
XNCR Sharpe Ratio Rank: 7272
Sharpe Ratio Rank
XNCR Sortino Ratio Rank: 7272
Sortino Ratio Rank
XNCR Omega Ratio Rank: 6868
Omega Ratio Rank
XNCR Calmar Ratio Rank: 7070
Calmar Ratio Rank
XNCR Martin Ratio Rank: 6666
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Xencor, Inc. (XNCR) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


XNCRBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-1.03

Sortino ratioReturn per unit of downside risk

-0.99

Omega ratioGain probability vs. loss probability

1.20

1.37

-0.17

Calmar ratioReturn relative to maximum drawdown

1.51

2.78

-1.27

Martin ratioReturn relative to average drawdown

2.75

12.44

-9.68

Dividends

Dividend History


Xencor, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Xencor, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Xencor, Inc. was 87.01%, occurring on Aug 11, 2025. The portfolio has not yet recovered.

The current Xencor, Inc. drawdown is 74.00%.


Related event

Drawdown

Fall

Recovery

Underwater

2025 bear market2025
-87.01%Aug 2025
4y 6mo
5y 4moFeb 2021 - now
2016 bear market2016
-58.51%Feb 2016
6mo 23d7mo 11d
1y 1moJul 2015 - Sep 2016
COVID crash2020
-56.58%Mar 2020
1y 6mo9mo 27d
2y 3moSep 2018 - Jan 2021
2014 bear market2014
-42.52%May 2014
2mo 4d7mo 1d
9mo 5dMar 2014 - Dec 2014
2017 bear market2017
-32.05%Nov 2017
11mo3mo 26d
1y 2moDec 2016 - Feb 2018

Drawdown Indicators


XNCRBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-87.01%

-56.78%

-30.23%

Max Drawdown (1Y)

Largest decline over 1 year

-42.61%

-9.10%

-33.51%

Max Drawdown (3Y)

Largest decline over 3 years

-73.92%

-18.90%

-55.02%

Max Drawdown (5Y)

Largest decline over 5 years

-83.89%

-25.43%

-58.46%

Max Drawdown (10Y)

Largest decline over 10 years

-87.01%

-33.92%

-53.09%

Current Drawdown

Current decline from peak

-74.00%

-1.80%

-72.20%

Average Drawdown

Average peak-to-trough decline

-36.43%

-10.71%

-25.72%

Ulcer Index

Depth and duration of drawdowns from previous peaks

23.32%

2.03%

+21.29%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Xencor, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Xencor, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for XNCR relative to other companies in the Biotechnology industry. Currently, XNCR has a P/S ratio of 11.2. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for XNCR in comparison with other companies in the Biotechnology industry. Currently, XNCR has a P/B value of 2.0. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with XNCR

Add Xencor, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with XNCR